In general, the clinical examination of breast cancer involves the use of staining methods such as IHC and fluorescence in situ hybridization (FISH) to visualize and evaluate the expression of each receptor (ER, PR, and HER2) in tissue sections, which are then classified into four classes. Here, ERBB2 is linked to breast cancer.